Christel Iffland, PhD

Senior Vice President, Antibody Technologies at OmniAb

Speaker

Christel Iffland is Senior Vice President of Antibody Technologies at OmniAb. Dr. Iffland joined the OmniAb team in 2017 from Merck KGaA/EMD Serono where she previously served as Associate Director of Antibody Technologies, a Senior Scientist of Phage Technologies and Structural Biology and Group Leader of Antibody Display Technologies and was one of the first industry users of the OmniRat® technology. Dr. Iffland supports current and new partnerships and collaborations for OmniAb, providing scientific guidance and input. Additionally, she contributes to the continued growth and next-generation innovation of the technology, and to the technical assessment of new opportunities. Dr. Iffland received her PhD. in molecular and cell biology from the Université de Nice Sophia-Antipolis in Nice, France and completed post-doctoral research training at both the Dana-Farber Cancer Institute at Harvard Medical School and the Albert Einstein College of Medicine. Dr. Iffland is an author of numerous scientific publications and patents.